Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non-Ashkenazi Jewish ancestry-Reference-Cited by-同舟云学术

Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non-Ashkenazi Jewish ancestry

Published:2017-06-22 Issue:10 Volume:32 Page:1432-1438
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Lee Annie J.¹,Wang Yuanjia¹,Alcalay Roy N.²³,Mejia-Santana Helen²,Saunders-Pullman Rachel⁴,Bressman Susan⁴,Corvol Jean-Christophe⁵⁶⁷⁸⁹,Brice Alexis⁵⁶⁷⁸⁹,Lesage Suzanne⁵⁶⁷⁸⁹,Mangone Graziella⁵⁶⁷⁸⁹,Tolosa Eduardo¹⁰¹¹¹²,Pont-Sunyer Claustre¹⁰¹¹,Vilas Dolores¹⁰¹¹,Schüle Birgitt¹³,Kausar Farah¹³,Foroud Tatiana¹⁴,Berg Daniela¹⁵,Brockmann Kathrin¹⁶,Goldwurm Stefano¹⁷,Siri Chiara¹⁷,Asselta Rosanna¹⁸¹⁹,Ruiz-Martinez Javier²⁰²¹,Mondragón Elisabet²⁰²¹,Marras Connie²²,Ghate Taneera²²,Giladi Nir²³²⁴,Mirelman Anat²³²⁴,Marder Karen²³,

Affiliation:

1. Department of Biostatistics; Mailman School of Public Health, Columbia University; New York New York USA

2. Department of Neurology; College of Physicians and Surgeons, Columbia University; New York New York USA

3. Taub Institute for Research on Alzheimer's Disease and the Aging Brain; Columbia University; New York New York USA

4. Department of Neurology; Mount Sinai Beth Israel Medical Center; New York New York USA

5. Sorbonne Universités, Université Pierre et Marie Curie (UPMC Univ) Paris 06

6. Institut National de la Santé et de la Recherche Médicale; U1127 Paris France

7. Centre National de la Recherche Scientifique; UMR 7225 Paris France

8. Institut du Cerveau et de la Moelle Epinière (ICM), Hôpital Pitié-Salpêtrière, Département des maladies du système nerveux; F-75013 Paris France

9. Department of Neurology; Institut National de la Santé et de la Recherche Médicale, Assistance-Publique Hôpitaux de Paris; CIC-1422 Hôpital Pitié-Salpêtrière, Paris France. Assistance publique - Hôpitaux de Paris (AP-HP); 75015 Paris France

10. Neurology Service; Parkinson's disease and Movement Disorders Unit, Institut Clínic de Neurociències, Hospital Clínic de Barcelona, University of Barcelona; Barcelona Spain

11. Institut d'Investigacions Biomèdiques August Pi iSunyer; Barcelona Spain

12. Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas; Barcelona Spain

13. Parkinson's Institute and Clinical Center; Sunnyvale California USA

14. Department of Medical and Molecular Genetics; Indiana University; Indianapolis Indiana USA

15. Department of Neurology; Christian-Albrechts-University of Kiel and Hertie-Institute of Clinical Brain Research, University of Tübingen; Germany

16. Department of Neurodegeneration; Hertie-Institute of Clinical Brain Research, University of Tübingen and German Center for Neurodegenerative Diseases; Germany

17. Parkinson Institute, Azienda Socio Sanitaria Territoriale (ASST) “Gaetano Pini-CTO”; Milan Italy

18. Department of Biomedical Sciences; Humanitas University; Rozzano Milan Italy

19. Humanitas Clinical and Research Center; Milan Italy

20. Department of Neurology; Donostia University Hospital, Biodonostia Research Institute; San Sebastián (Gipuzkoa) Spain

21. Centre for Networked Biomedical Research on Neurodegenerative Diseases; Madrid Spain

22. Morton and Gloria Shulman Movement Disorders Centre and the Edmond J. Safra Program in Parkinson's Research; Toronto Canada

23. Sackler School of Medicine; Sagol School for Neurosciences, Tel Aviv University; Tel Aviv Israel

24. Neurological Institute; Tel Aviv Sourasky Medical Center; Tel Aviv Israel

Funder

National Institutes of Health

Michael J. Fox Foundation for Parkinson's Research

Parkinson Disease Foundation

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mds.27059/fullpdf

Reference20 articles.

1. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study;Healy;Lancet Neurol,2008

2. LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews;Ozelius;N Engl J Med,2006

3. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease;Clark;Neurology,2006

4. The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?;Orr-Urtreger;Neurology,2007

5. Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations;Alcalay;Mov Disord,2013

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-depth whole-genome sequencing identifies structure variants, copy number variants and short tandem repeats associated with Parkinson’s disease;npj Parkinson's Disease;2024-07-23

2. The p.Gly2019Ser is the commonest pathogenic mutation in the LRRK2 gene among Egyptians with familial and sporadic Parkinson's disease;2024-07-01

3. Expanding the Neurological Phenotype of Anderson–Fabry Disease: Proof of Concept for an Extrapyramidal Neurodegenerative Pattern and Comparison with Monogenic Vascular Parkinsonism;Cells;2024-06-29

4. Cerebral small vessel disease may not critically influence familial Parkinson’s disease;2024-06-26

5. Occupational Pesticide Exposure in Parkinson’s Disease Related to GBA and LRRK2 Variants;Journal of Parkinson's Disease;2024-06-04